Simona Grano assesses how variables including Europe’s strategic interests in the Indo-Pacific, U.S. Taiwan policy, and the U.S.-EU relationship in the second Trump administration will influence EU-Taiwan relations.

The report explores key takeaways from a conference held on January 15 in New York that explored the U.S.-Japan alliance at a pivotal moment

The authors share their insights on last week’s concurrent meetings of China’s legislature, the National People’s Congress, and its political advisory body, the Chinese People’s Political Consultative Conference.

The Asia Society Policy Institute’s Center for China Analysis is pleased to announce that Anthony Saich has been named a Non-Resident Honorary Senior Fellow on Chinese Politics and Society.

CCA Senior Fellow on Chinese Politics Guoguang Wu examines the ways in which Xi Jinping’s methods of exercising power, in particular his purges of handpicked allies, mirror those of his Communist forebears.

The paper unpacks what to expect at the annual dual meetings of the National Committee of the Chinese People’s Political Consultative Conference opening on March 4 and the National People’s Congress beginning on March 5.

The paper analyzes views of Donald Trump’s second term for Southeast Asia, assesses regional perceptions of risk in security and economic domains, and discusses how China might capitalize upon these perceptions.

The paper examines how China’s industrial overcapacity is impacting ASEAN economies across key sectors, analyzes responses by ASEAN countries and China, and offers policy recommendations to Washington and ASEAN governments.

This paper explores the generational shift within the Chinese Communist Party (CCP) as cadres born in the 1980s ascend through its ranks. Notably, one institution stands out among their educational backgrounds: Tsinghua University.

As part of CCA’s Cure4Cancer initiative, the paper analyzes the political and regulatory challenges to U.S.-China collaboration and offers policy recommendations for how to harmonize the two countries’ cancer clinical trials.